10
|
Ishii N, Matsumura T, Kinoshita H, Fukuda K, Motoshima H, Senokuchi T, Nakao S, Tsutsumi A, Kim-Mitsuyama S, Kawada T, Takeya M, Miyamura N, Nishikawa T, Araki E. Nifedipine Induces Peroxisome Proliferator-Activated Receptor-γ Activation in Macrophages and Suppresses the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice. Arterioscler Thromb Vasc Biol 2010; 30:1598-605. [DOI: 10.1161/atvbaha.109.202309] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Objective—
Nifedipine, an L-type calcium channel blocker, protects against the progression of atherosclerosis. We investigated the molecular basis of the antiatherosclerotic effect of nifedipine in macrophages and apolipoprotein E-deficient mice.
Methods and Results—
In macrophages, nifedipine increased peroxisome proliferator-activated receptor-γ (PPARγ) activity without increasing PPARγ-binding activity. Amlodipine, another L-type calcium channel blocker, and 1,2-bis-(o-aminophenoxy)-ethane-N,N,-N′,N′-tetraacetic acid tetraacetoxy-methyl ester (BAPTA-AM), a calcium chelator, decreased PPARγ activity, suggesting that nifedipine does not activate PPARγ via calcium channel blocker activity. Inactivation of extracellular signal-regulated kinase 1/2 suppressed PPARγ2-Ser112 phosphorylation and induced PPARγ activation. Nifedipine suppressed extracellular signal-regulated kinase 1/2 activation and PPARγ2-Ser112 phosphorylation, and mutating PPARγ2-Ser112 to Ala abrogated nifedipine-mediated PPARγ activation. These results suggested that nifedipine inhibited extracellular signal-regulated kinase 1/2 activity and PPARγ2-Ser112 phosphorylation, leading to PPARγ activation. Nifedipine inhibited lipopolysaccharide-induced monocyte chemoattractant protein-1 expression and induced ATP-binding cassette transporter A1 mRNA expression, and these effects were abrogated by small interfering RNA for PPARγ. Furthermore, in apolipoprotein E-deficient mice, nifedipine treatment decreased atherosclerotic lesion size, phosphorylation of PPARγ2-Ser112 and extracellular signal-regulated kinase 1/2, and monocyte chemoattractant protein-1 mRNA expression and increased ATP-binding cassette transporter A1 expression in the aorta.
Conclusion—
Nifedipine unlike amlodipine inhibits PPARγ-Ser phosphorylation and activates PPARγ to suppress monocyte chemoattractant protein-1 expression and induce ATP-binding cassette transporter A1 expression in macrophages. These effects may induce antiatherogenic effects in hypertensive patients.
Collapse
Affiliation(s)
- Norio Ishii
- From the Departments of Metabolic Medicine (N.I., T.M., H.K., K.F., H.M., T.S., A.T., N.M., T.N., E.A.), Pharmacology and Molecular Therapeutics (S.K.-M.), and Cell Pathology (M.T.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Laboratory of Nutrition Chemistry, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, Japan (T.K.); Department of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, Kumamoto
| | - Takeshi Matsumura
- From the Departments of Metabolic Medicine (N.I., T.M., H.K., K.F., H.M., T.S., A.T., N.M., T.N., E.A.), Pharmacology and Molecular Therapeutics (S.K.-M.), and Cell Pathology (M.T.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Laboratory of Nutrition Chemistry, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, Japan (T.K.); Department of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, Kumamoto
| | - Hiroyuki Kinoshita
- From the Departments of Metabolic Medicine (N.I., T.M., H.K., K.F., H.M., T.S., A.T., N.M., T.N., E.A.), Pharmacology and Molecular Therapeutics (S.K.-M.), and Cell Pathology (M.T.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Laboratory of Nutrition Chemistry, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, Japan (T.K.); Department of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, Kumamoto
| | - Kazuki Fukuda
- From the Departments of Metabolic Medicine (N.I., T.M., H.K., K.F., H.M., T.S., A.T., N.M., T.N., E.A.), Pharmacology and Molecular Therapeutics (S.K.-M.), and Cell Pathology (M.T.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Laboratory of Nutrition Chemistry, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, Japan (T.K.); Department of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, Kumamoto
| | - Hiroyuki Motoshima
- From the Departments of Metabolic Medicine (N.I., T.M., H.K., K.F., H.M., T.S., A.T., N.M., T.N., E.A.), Pharmacology and Molecular Therapeutics (S.K.-M.), and Cell Pathology (M.T.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Laboratory of Nutrition Chemistry, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, Japan (T.K.); Department of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, Kumamoto
| | - Takafumi Senokuchi
- From the Departments of Metabolic Medicine (N.I., T.M., H.K., K.F., H.M., T.S., A.T., N.M., T.N., E.A.), Pharmacology and Molecular Therapeutics (S.K.-M.), and Cell Pathology (M.T.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Laboratory of Nutrition Chemistry, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, Japan (T.K.); Department of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, Kumamoto
| | - Saya Nakao
- From the Departments of Metabolic Medicine (N.I., T.M., H.K., K.F., H.M., T.S., A.T., N.M., T.N., E.A.), Pharmacology and Molecular Therapeutics (S.K.-M.), and Cell Pathology (M.T.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Laboratory of Nutrition Chemistry, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, Japan (T.K.); Department of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, Kumamoto
| | - Atsuyuki Tsutsumi
- From the Departments of Metabolic Medicine (N.I., T.M., H.K., K.F., H.M., T.S., A.T., N.M., T.N., E.A.), Pharmacology and Molecular Therapeutics (S.K.-M.), and Cell Pathology (M.T.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Laboratory of Nutrition Chemistry, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, Japan (T.K.); Department of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, Kumamoto
| | - Shokei Kim-Mitsuyama
- From the Departments of Metabolic Medicine (N.I., T.M., H.K., K.F., H.M., T.S., A.T., N.M., T.N., E.A.), Pharmacology and Molecular Therapeutics (S.K.-M.), and Cell Pathology (M.T.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Laboratory of Nutrition Chemistry, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, Japan (T.K.); Department of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, Kumamoto
| | - Teruo Kawada
- From the Departments of Metabolic Medicine (N.I., T.M., H.K., K.F., H.M., T.S., A.T., N.M., T.N., E.A.), Pharmacology and Molecular Therapeutics (S.K.-M.), and Cell Pathology (M.T.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Laboratory of Nutrition Chemistry, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, Japan (T.K.); Department of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, Kumamoto
| | - Motohiro Takeya
- From the Departments of Metabolic Medicine (N.I., T.M., H.K., K.F., H.M., T.S., A.T., N.M., T.N., E.A.), Pharmacology and Molecular Therapeutics (S.K.-M.), and Cell Pathology (M.T.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Laboratory of Nutrition Chemistry, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, Japan (T.K.); Department of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, Kumamoto
| | - Nobuhiro Miyamura
- From the Departments of Metabolic Medicine (N.I., T.M., H.K., K.F., H.M., T.S., A.T., N.M., T.N., E.A.), Pharmacology and Molecular Therapeutics (S.K.-M.), and Cell Pathology (M.T.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Laboratory of Nutrition Chemistry, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, Japan (T.K.); Department of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, Kumamoto
| | - Takeshi Nishikawa
- From the Departments of Metabolic Medicine (N.I., T.M., H.K., K.F., H.M., T.S., A.T., N.M., T.N., E.A.), Pharmacology and Molecular Therapeutics (S.K.-M.), and Cell Pathology (M.T.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Laboratory of Nutrition Chemistry, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, Japan (T.K.); Department of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, Kumamoto
| | - Eiichi Araki
- From the Departments of Metabolic Medicine (N.I., T.M., H.K., K.F., H.M., T.S., A.T., N.M., T.N., E.A.), Pharmacology and Molecular Therapeutics (S.K.-M.), and Cell Pathology (M.T.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Laboratory of Nutrition Chemistry, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, Japan (T.K.); Department of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, Kumamoto
| |
Collapse
|